Prudential Financial’s Solid Biosciences SLDB Stock Holding History

Prudential Financial’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$130K	Buy	+12,965	New	+$98.3K	﹤0.01%	2296
2025 Q4	–	Sell	-60,990	Closed	-$376K	–	2420
2025 Q3	$376K	Buy	+60,990	New	+$357K	﹤0.01%	2036
2025 Q1	–	Sell	-109,105	Closed	-$436K	–	2371
2024 Q4	$436K	Buy	109,105 +45,400	+71%	+$249K	﹤0.01%	1886
2024 Q3	$444K	Buy	+63,705	New	+$517K	﹤0.01%	2260
2022 Q4	–	Sell	-3,080	Closed	-$22K	–	2692
2022 Q3	$22K	Hold	3,080	–	–	﹤0.01%	2626
2022 Q2	$28K	Buy	+3,080	New	+$32K	﹤0.01%	2628
2021 Q4	–	Sell	-698	Closed	-$25K	–	2693
2021 Q3	$25K	Buy	+698	New	+$29.6K	﹤0.01%	2574

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Prudential Financial's SLDB Position: Q2 2026 in Review

Prudential Financial opened a new position in Solid Biosciences (SLDB) in Q2 2026: 12,965 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #2296 among its holdings. This is a return to the name: Prudential Financial previously reported a position in SLDB as recently as Q3 2025.

Prudential Financial first reported a position in SLDB in Q3 2021 and has held it in 7 quarters since. The position peaked at $444K in Q3 2024. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

Prudential Financial held 12,965 shares of Solid Biosciences worth $130K as of Q2 2026.
Solid Biosciences was a new Prudential Financial position in Q2 2026.
Solid Biosciences made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2296 holding.
Prudential Financial first reported a position in Solid Biosciences in Q3 2021 and has held it in 7 quarters since.
Prudential Financial's Solid Biosciences position peaked at $444K in Q3 2024.
156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.